SecSonar.com

Danaher Corporation (DHR)

Danaher Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Danaher Corporation (DHR) is a Medical - Diagnostics & Research company based in US with a market capitalization of $130.1B. Revenue grew 2.9% year-over-year and the company generated $5.3B in free cash flow. This page tracks DHR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 61K employees · IPO Dec 29, 1978

Valuation

Valuation & price

$161.91 · as of May 17, 2026 · -33.1% vs 52w high

31.9

P/E ratio

Latest-FY diluted EPS

2.48

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$242$203$164Jul 25Dec 25Jul 26Jul 7, 25$199.63Jul 9, 25$200.96Jul 11, 25$204.85Jul 15, 25$192.86Jul 17, 25$194.79Jul 21, 25$188.07Jul 23, 25$197.89Jul 25, 25$205.48Jul 29, 25$206.85Jul 31, 25$197.16Aug 4, 25$197.46Aug 6, 25$195.17Aug 11, 25$199.76Aug 13, 25$209.14Aug 15, 25$210.93Aug 19, 25$212.20Aug 21, 25$203.90Aug 25, 25$207.73Aug 27, 25$205.00Aug 29, 25$205.82Sep 3, 25$199.44Sep 5, 25$200.21Sep 9, 25$194.33Sep 11, 25$195.16Sep 16, 25$190.47Sep 18, 25$195.27Sep 22, 25$190.46Sep 24, 25$185.91Sep 26, 25$184.84Sep 30, 25$198.26Oct 2, 25$210.33Oct 6, 25$211.71Oct 8, 25$204.96Oct 10, 25$202.46Oct 14, 25$206.15Oct 16, 25$210.92Oct 21, 25$220.77Oct 23, 25$222.73Oct 27, 25$221.01Oct 29, 25$214.01Oct 31, 25$215.38Nov 4, 25$213.83Nov 6, 25$210.67Nov 10, 25$211.17Nov 12, 25$219.40Nov 14, 25$221.21Nov 18, 25$225.51Nov 20, 25$222.18Nov 25, 25$230.77Nov 28, 25$226.78Dec 2, 25$226.59Dec 4, 25$227.13Dec 8, 25$224.48Dec 10, 25$230.42Dec 12, 25$226.33Dec 16, 25$224.70Dec 18, 25$224.35Dec 22, 25$228.01Dec 24, 25$231.47Dec 29, 25$230.63Jan 2, 26$230.40Jan 6, 26$236.59Jan 8, 26$235.00Jan 12, 26$239.00Jan 14, 26$237.95Jan 16, 26$235.99Jan 21, 26$242.05Jan 23, 26$235.01Jan 27, 26$235.75Jan 29, 26$219.62Feb 2, 26$223.42Feb 4, 26$219.53Feb 9, 26$216.66Feb 11, 26$219.98Feb 13, 26$212.58Feb 18, 26$208.56Feb 20, 26$209.50Feb 24, 26$209.19Feb 26, 26$209.36Mar 2, 26$206.00Mar 4, 26$204.73Mar 6, 26$195.50Mar 10, 26$195.22Mar 12, 26$186.26Mar 17, 26$195.21Mar 19, 26$190.11Mar 23, 26$190.00Mar 25, 26$187.15Mar 27, 26$181.52Mar 31, 26$189.60Apr 2, 26$191.12Apr 7, 26$191.01Apr 9, 26$192.99Apr 13, 26$195.87Apr 15, 26$198.14Apr 17, 26$194.75Apr 22, 26$184.04Apr 24, 26$177.25Apr 28, 26$178.98Apr 30, 26$178.95May 4, 26$174.04May 6, 26$174.92May 8, 26$171.16May 12, 26$166.26May 14, 26$164.54May 18, 26$163.86May 20, 26$171.12May 22, 26$172.00May 28, 26$180.63Jun 1, 26$179.87Jun 3, 26$178.08Jun 5, 26$184.30Jun 9, 26$188.41Jun 11, 26$180.79Jun 15, 26$181.10Jun 17, 26$177.76Jun 22, 26$178.19Jun 24, 26$188.87Jun 26, 26$196.19Jul 2, 26$197.93
$161.9152-week range$242.05
Loading valuation history…

Fundamentals

Key fundamentals

$130.1B

Market cap

2.9%

Revenue growth (YoY)

60.9%

Gross margin

$5.3B

Free cash flow (USD)

$13.8B

Net debt

-3.2%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$16.9BFY 2017$18.3BFY 2018$17.0BFY 2019$17.9BFY 2020$22.3BFY 2021$29.5BFY 2022$26.6BFY 2023$23.9BFY 2024$23.9BFY 2025$24.6B
$16.9B$24.6B

Free cash flow by year

2016 → 2025

FY 2016$2.9BFY 2017$2.9BFY 2018$3.4BFY 2019$3.3BFY 2020$5.4BFY 2021$7.1BFY 2022$7.4BFY 2023$5.8BFY 2024$5.3BFY 2025$5.3B
$2.9B$5.3B

Gross margin by year

2021 → 2025

FY 202161.0%FY 202260.8%FY 202358.7%FY 202459.5%FY 202560.9%
61.0%60.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 21, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDebt IssuanceJun 3, 2026Filing
  • 8-K eventShareholder Meeting ResultsMay 7, 2026Filing
  • Insider sellInsider Sell $237KSPOON ALAN G · Director · $237.2KMay 4, 2026Filing
  • 8-K eventDebt IssuanceApr 29, 2026Filing
  • Quarterly report10-Q FiledApr 21, 2026Filing
  • 8-K eventEarnings ReleaseApr 21, 2026Filing
  • 8-K eventCredit AgreementApr 17, 2026Filing

Questions

Frequently asked questions

What is Danaher Corporation's market cap?

Danaher Corporation (DHR) has a market capitalization of $130.1B.

What is DHR's P/E ratio?

DHR trades at a price-to-earnings ratio of 31.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is DHR's price-to-book (P/B) ratio?

DHR trades at 2.48 times book value per share.

Are insiders buying DHR stock?

SEC Form 4 filings show no open-market insider buys at Danaher Corporation in the last 90 days (1 sell).

Same arena

Related companies in Medical - Diagnostics & Research

TMO

Thermo Fisher Scientific Inc.

$185.1B

IDXX

IDEXX Laboratories, Inc.

$44.5B

A

Agilent Technologies, Inc.

$38.7B

NTRA

Natera, Inc.

$31.7B

IQV

IQVIA Holdings Inc.

$30.5B

WAT

Waters Corporation

$25B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.